RXST's Quality Score fell 1 point on Tue, Nov 10, to -2. Trading went back to normal after a busy day (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 63% from its Dec 11, 2025 high.
“In the third quarter of 2026, total revenue was $24.6 million, down 19% from the prior-year period, primarily reflecting ongoing competitive pressures.”
| Since its 2024 high | Down 92% |
| Latest filing | 8-K, Nov 3 |
After its last 4 reports it closed -4.8% on average, higher 1 of 4 times.
Poorfor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
RXST is #72 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 72 |
Expected to report Wed Feb 24, after the close (in 106 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $24.6M, 19% less than a year ago; a loss of $0.39 a share, from $0.24.
“In the third quarter of 2026, total revenue was $24.6 million, down 19% from the prior-year period, primarily reflecting ongoing competitive pressures.”
RXST's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“Third-quarter gross margin was 73.6%, compared with 79.9% in the prior-year period, primarily reflecting an increase in inventory reserves and higher inventory costs for LAL and LDD, partially offset by favorable product mix.”
From its results filing (SEC filing · Nov 3)
Its share count grew 14% a year over 3 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 3, 2026 | -10.5% | +8.7% | +6.8% |
| Aug 5, 2026 | -4.6% | -3.3% | +12.2% |
| May 6, 2026 | -8.4% | -14.4% | -18.1% |
Sales grew in four of the last five years, to $134M in 2025. It made a profit in one of the six years.
RSI 50.4, MACD above signal, below both averages. Not scored.
4 insiders sold $118K across 4 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: RXST is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
“Competition in the surgical ophthalmology market is intense and is primarily driven by technological innovation and the regulatory approval required to commercialize products in the key markets around the world.”
RXST scores -2 today, which Breakaway calls Poor. It is #72 of 84 in Medical Devices by Quality Score, with 3 of 14 chart checks firing. Down 63% from its Dec 11, 2025 high. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
RXST scores -2 today, which Breakaway calls Poor (below zero). That is #72 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind RXST's -2.
4 insiders sold $118K across 4 filings in the last 6 months. No open-market buys on record. The newest is Mark Wilterding, Chief Financial Officer, who sold $54K on Sep 2. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.